stocksLUPIN
2,201.80+0.3 (+0.01%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Lupin Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Lupin Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General20 Aug 2026
    Exclusive License Agreement With Visus Therapeutics, Inc. U.S.A.
    VISUfarma B.V., the Netherlands, a wholly owned subsidiary of the Company, has entered into an Exclusive License Agreement with Visus Therapeutics, Inc. U.S.A.
  2. Demise18 Aug 2026
    Announcement under Regulation 30 (LODR)-Demise
    Intimation of Demise of Dr. Sofia Mumtaz, President, Legal & Compliance, Canada, ANZ & NEA Business, a Senior Management Personnel of the Company.
  3. Press Release / Media Release17 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Lupin Announces Approval from U.S. FDA for Pitolisant Tablets.
  4. Press Release / Media Release10 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States.
  5. Analyst / Investor Meet10 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation about participating in the Analyst/Institutional Investors Meet.
  6. Newspaper Publication8 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of Newspaper publication in respect of Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
  7. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Link of Audio recording of the Earnings Call-Q1 FY27.
  8. Press Release / Media Release6 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Lupin Q1 FY2027 Results
  9. Outcome of Board Meeting6 Aug 2026
    Board Meeting Outcome for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
    Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
  10. AGM4 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Details of Voting Results of the Forty-Fourth Annual General Meeting along with the Consolidated Scrutinizer''s Report.
  11. AGM4 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of the Forty-Fourth Annual General Meeting held on August 04, 2026.
  12. Press Release / Media Release31 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Lupin Announces the approval of Diazepam Injection, USP in the United States.
  13. Press Release / Media Release31 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection.
  14. Analyst / Investor Meet22 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Earnings Call for Q1 FY27
  15. Board Meeting22 Jul 2026
    Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
    Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated ....
  16. Acquisition21 Jul 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Lupin Inc. U.S.A., wholly owned subsidiary of the Company has entered into a licensing agreement in exchange of 332,000 Common Shares of Kaveri Therapeutics, Inc. U.S.A.
  17. Newspaper Publication14 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Advertisement relating to Annual General Meeting and e-voting related information.
  18. Press Release / Media Release14 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Lupin Recognized Among India''s Best Employers in the Nation-Builders Category by Great Place to Work India 2026.
  19. Business Responsibility and Sustainability Reporting (BRSR)13 Jul 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report of the Company for FY 2025-26.
  20. Reg. 34 (1) Annual Report13 Jul 2026
    Reg. 34 (1) Annual Report.
    Integrated Report of the Company for FY 2025-26.

Frequently Asked Questions

Where can I download the annual report of Lupin Ltd.?
Annual reports of Lupin Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Lupin Ltd.?
Quarterly earnings results and presentations of Lupin Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Lupin Ltd. publish earnings call transcripts?
Earnings call transcripts of Lupin Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Lupin Ltd.?
Investor presentations and annual day presentations of Lupin Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Lupin Ltd.?
Corporate announcements and regulatory filings of Lupin Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Lupin Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Lupin Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Lupin Ltd.?
The ISIN (International Securities Identification Number) of Lupin Ltd. is INE326A01037. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Lupin Ltd. listed?
Lupin Ltd. is listed on NSE and BSE. The NSE symbol is LUPIN and the BSE code is -.
Where can I find the shareholding pattern of Lupin Ltd.?
The quarterly shareholding pattern of Lupin Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Lupin Ltd. on Sharpely?
Share price data for Lupin Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.